Sign in

CIK 0001635088 · Large accelerated filer

Roivant Sciences Ltd.

Sign in to watch
Ticker
ROIV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
Bermuda
Entity type
operating
EIN
981173944
Phone
441-295-5950
Business address
7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$85,719,562
in 13 filings, $45.5M under 10b5-1 plans

Net −$85,719,562. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Venker Eric −$43.7M President & Immunovant CEO sold 59% of stake
  2. Sukhatme Mayukh −$27.7M President & CIO sold 4% of stake
  3. Pulik Richard −$12.5M CFO sold 57% of stake
  4. Fitzgerald Meghan −$1.0M Director sold 41% of stake
  5. Epperly Melissa B, −$837K Director sold 60% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-09-16 Fitzgerald Meghan Director Grant or award +5,054 41,162
2026-09-16 Fitzgerald Meghan Director Grant or award · Stock Option (Right to Buy) +10,531 10,531
2026-09-16 MOMTAZEE JAMES C Director Grant or award +5,054 111,959
2026-09-16 MOMTAZEE JAMES C Director Grant or award · Stock Option (Right to Buy) +10,531 10,531
2026-09-16 MANCHESTER KEITH S Director Grant or award +5,054 1,753,457
2026-09-16 MANCHESTER KEITH S Director Grant or award · Stock Option (Right to Buy) +10,531 10,531
2026-09-15 Epperly Melissa B, Director Sale 10b5-1 −4,338 $39.65 $172K 10,500
2026-09-15 Epperly Melissa B, Director Sale 10b5-1 −600 $40.38 $24K 9,900
2026-09-15 Fitzgerald Meghan Director Sale 10b5-1 −4,712 $39.68 $187K 36,508
2026-09-15 Fitzgerald Meghan Director Sale 10b5-1 −400 $40.45 $16K 36,108
2026-09-10 Epperly Melissa B, Director Shares withheld for taxes −2,179 $40.94 $89K 14,838
2026-09-10 Oren Ilan Director Shares withheld for taxes −2,378 $40.94 $97K 118,626
2026-09-10 Fitzgerald Meghan Director Shares withheld for taxes −1,743 $40.94 $71K 41,220
2026-09-10 MOMTAZEE JAMES C Director Shares withheld for taxes −2,905 $40.94 $119K 106,905
2026-09-10 Gold Daniel Allen Director Shares withheld for taxes −5,133 $40.94 $210K 8,960,761
2026-09-08 Fitzgerald Meghan Director Option exercise 10b5-1 +20,000 $8.80 $176K 62,963
2026-09-08 Fitzgerald Meghan Director Sale 10b5-1 −20,000 $39.90 $798K 42,963
2026-09-08 Fitzgerald Meghan Director Option exercise · Stock Option (Right to Buy) 10b5-1 −20,000 18,578
2026-08-28 Venker Eric President & Immunovant CEO Option exercise 10b5-1 +200,000 $3.85 $770K 1,799,154
2026-08-28 Venker Eric President & Immunovant CEO Sale 10b5-1 −166,182 $35.63 $5.9M 1,632,972

Page 4 of 29 · 570 trades